| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Meetings and Conferences |
|
|
| |
Clinical Data Disclosure Webinar | |
| |
March 17, 2008 |
|
|
| |
|
|
| |
|
|
|
ExL Pharma, Webinar
April 17, 2008
Evaluating current requirements and regulations Developing a corporate clinical data disclosure deployment strategy Determining what infrastructure and operational processes need to be in place to effectively disclose clinical data How to handle proprietary information and avoid promotional language Strategies for disclosing studies for newly acquired/merged companies and for partnership-sponsored studies Understanding how results disclosure impacts publication
|
|
|
|
|
|
|
|
Organized by:
|
|
ExL Pharma |
|
|
Invited Speakers:
|
|
John McKenney
President & CEO
SEC ASSOCIATES, INC Michael Rubison, PhD
President and Senior Consultant
FLINT HILL CONSULTING LLC Pat Teden, MBA
Principal
TEDEN CONSULTING LLC.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
N/A
|
|
|
|
|
|
|
|
Registration:
|
|
http://www.exlpharma.com/eventRegister.php?id=113
|
|
|
E-mail:
|
|
info@exlpharma.com
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|